News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

TARIS Biomedical Appoints Christopher Searcy as the Company’s Chief Business Officer



7/25/2011 8:43:50 AM

LEXINGTON, Mass.--(BUSINESS WIRE)--TARIS Biomedical®, a specialty pharmaceutical company pioneering the development of innovative, targeted therapies using drug delivery to treat bladder diseases, announced today that Dr. Christopher Searcy has joined the company as its Chief Business Officer and Senior VP of Corporate Development. In this role he will have global responsibility for the business strategy for TARIS including corporate partnerships and other strategic alliances involving the company’s products and technologies.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES